1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Vericiguat tablet: new trials by email Literature Review of Vericiguat tablet trials Research Report on Vericiguat tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) Vericiguat tablet, Vericiguat suspension, Placebo tablet - Heart Failure, Left Ventricular Systolic Dysfunction | Phase 2 / Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 342 | 2023-05-31 | 2026-10-30 |
Heart Failure (1) · Ventricular Dysfunction, Left (1)
Belgium (1) · Brazil (1) · Canada (1) · Colombia (1) · Croatia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Ireland (1) · Italy (1) · Malaysia (1) · Mexico (1) · Netherlands (1)